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Injury Is a Major Inducer of Epidermal Innate
Immune Responses during Wound Healing
K. Markus Roupe´1, Mads Nybo3, Ulf Sjo¨bring1, Per Alberius4, Artur Schmidtchen2 and Ole E. Sørensen1
We examined the importance of injury for the epidermal innate immune response in human skin wounds. We
found that injury, independent of infiltrating inflammatory cells, generated prominent chemotactic activity toward
neutrophils in injured skin because of IL-8 production. Furthermore, injury was a major inducer of the expression
of antimicrobial (poly)peptides (AMPs) in skin wounds. In human skin, these injury-induced innate immune
responses were mediated by activation of the epidermal growth factor receptor (EGFR). Consequently, inhibition
of the EGFR blocked both the chemotactic activity generated in injured skin and the expression of the majority of
the AMPs. The importance of injury was confirmed in mouse experiments in vivo, in which injury independent of
infection was a potent inducer of AMPs in skin wounds. To our knowledge, these data thereby provide a
previously unreported molecular link between injury and neutrophil accumulation and identify the molecular
background for the vast expression of IL-8 and AMPs in wounded epidermis. Conceptually, these data show that
the growth factor response elicited by injury is important for the recruitment of neutrophils in skin wounds.
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INTRODUCTION
The epidermis has an important role in the protection against
microbes during skin infections and wound healing and is
consequently an integral part of the innate immune system. In
wound healing, the production and release of inflammatory
cytokines ensure a rapid recruitment of neutrophils to the
wound site. This recruitment of neutrophils is essential for
keeping the wound free of infection (Martin and Leibovich,
2005). Epidermal keratinocytes are an important source of
neutrophil chemotactic cytokines such as CXCL-1 (Gro-a)
and IL-8 (CXCL-8), both found to be major chemotactic
cytokines in human wound fluid in vivo (Rennekampff et al.,
2000). IL-8 is upregulated in keratinocytes by proinflamma-
tory cytokines such as IL-1 and TNF-a (Larsen et al., 1989).
In addition, increased IL-8 production can be induced by
various pathways and agonists including Toll-like receptors
(TLRs) (Pivarcsi et al., 2003), retinoic acid (Dai et al., 2004),
TNF-related apoptosis inducing ligand (TRAIL) (Leverkus et al.,
2003), LL-37 (Murakami et al., 2004), and the ligands of the
epidermal growth factor receptor (EGFR) (Miller et al., 2005;
Pastore et al., 2005) in vitro. However, the pathway respon-
sible for IL-8 production in wounded epidermis has not been
identified.
Apart from production of chemotactic cytokines, the epi-
dermis also produces antimicrobial (poly)peptides (AMPs).
During wound healing, the infiltration of inflammatory cells
is accompanied with expression of the major human epidermal
AMPs, including hBD-2 (Schmid et al., 2001), hBD-3 (Sørensen
et al., 2006), hCAP-18/LL-37 (Dorschner et al., 2001), psoriasin
(Lee and Eckert, 2007), calgranulins (Thorey et al., 2001), and
elafin (vanBergen et al., 1996).
Microbes stimulate the AMP expression in human skin
and keratinocytes mostly through TLR signaling (Gla¨ser
et al., 2005; Bu¨chau et al., 2007; Abtin et al., 2008; Gerstel
et al., 2009). Furthermore, IL-1 (Liu et al., 2003; Sørensen et al.,
2005) and vitamin D (Weber et al., 2005; Schauber et al.,
2007) induce AMP expression either alone or in combination
with TLR signaling (Schauber et al., 2007). Although induced
expression has been found for many AMPs during wound
healing, less is known about the pathways leading to their
induced expression after wounding. For example, psoriasin,
important for its prominent activity against Escherichia coli
(Gla¨ser et al., 2005), is induced in skin wounds through
unidentified pathways (Lee and Eckert, 2007).
We have previously shown that epidermal injury leads to
the expression of three AMPs, SLPI, NGAL, and hBD-3,
through activation of EGFR (Sørensen et al., 2006). EGFR is
known to be activated after injury by the so-called
‘transactivation’ (Tokumaru et al., 2000). During this process,
membrane-bound metalloproteases of the ADAM (A Disin-
tegrin And Metalloprotease) family become activated in
response to injury. Their subsequent shedding of the pool of
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EGFR ligands on the keratinocyte cell surfaces lead to a local
activation of the EGFR in an autocrine manner. Accordingly,
injury-induced EGFR activation provides a molecular link
between injury and the expression of these AMP during
wound healing.
Inflammation is a potent inducer of AMP and cytokines,
and in inflammatory skin diseases such as psoriasis, there is a
potent induction of epidermal AMP expression (Harder and
Schro¨der, 2005). Accordingly, it is not clear whether the major
epidermal AMP and cytokine expression in wounds is caused
by stimuli from the infiltrating inflammatory cells or represents
an inherent epidermal reaction to injury. In this study, we
show that epidermal reaction to injury is a major inducer of
epidermal AMP and cytokine expression in skin wounds.
RESULTS
AMP protein expression increases over time in human skin
wounds
To find the time point for maximal AMP expression,
standardized human skin wounds were made by punch
biopsy. New punch biopsy samples encompassing the wound
edge were taken at variable time points after the initial
biopsies from the same donor. The time course of the protein
expression of SLPI, hBD-2, and elafin in these in vivo
skin wounds were examined by immunohistochemistry.
SLPI expression is induced by injury through activation of
the EGFR, hBD-2 expression is known to be IL-1-dependent,
and elafin is induced through an unknown signaling pathway.
Despite being regulated by different pathways, we found
that the AMP expression increased over time with significant
presence of all three AMPs at days 3–4 after wounding
(Figure 1).
The major part of AMP expression in human skin wounds is
injury-induced and dependent on EGFR activation
Owing to the observed time course of AMP expression in the
wounded human skin, we investigated the gene expression in
the wounded skin/epidermis on day 4 after injury by cDNA
microarray. To exclude that changes in gene expression
levels were not simply due to variable amount of keratino-
cytes in our samples, we examined the expression of
keratin 14 constitutively expressed in epidermal keratinocytes
(Table 1). We also checked for infiltration of inflammatory
cells in the different samples by monitoring markers for
inflammatory cells. No major differences in expression
between the samples were found (Supplementary Table 1).
The microarray data confirmed the induced expression of
SLPI, hBD-2, and elafin detected by immunohistochemistry
(Figure 1). Furthermore, we found significantly increased
expression of other AMPs reported to be induced in wounds:
hBD-3 (Sørensen et al., 2006), NGAL (Sørensen et al., 2006),
psoriasin (Lee and Eckert, 2007), and calgranulins A and B
(Thorey et al., 2001) (Table 1). In addition, we found
increased expression of haptocorrin, lysozyme, S100A15,
and lactoferrin (Table 1), which have not previously been
described to be induced in skin wounds. Consequently, their
Day 0
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Figure 1. AMP expression increases over time in skin wounds in vivo. Samples of normal skin and of wounds 2, 3, and 4 days old were immunostained
for SLPI, hBD-2, elafin, and lactoferrin (LF). Normal skin was obtained by punch biopsy. New biopsies of the wound samples were taken on days 2, 3, and
4 around the edges of the initial biopsy. Color was developed with Vulcan Fast Red Chromogen, and Harris Hematoxylin was used for counterstaining.
Bars¼ 100 mm (black).
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induction was further investigated by quantitative real-time
PCR (qRT-PCR) in two skin wound samples. This confirmed
the induction of S100A15 and haptocorrin (data not shown).
However, induction of lysozyme could not be detected by
qRT-PCR. By qRT-PCR, lactoferrin expression was detected in
wounded skin but not in normal skin. Lactoferrin expression
Table 1. Fold changes of AMPs and cytokines
In vivo Ex vivo
Day 4 Day 4 Day 4 + AG-1478
Affymetrix ID Protein Fold change1 Hybr. value2 Fold change1 Hybr. value2 Fold change1 Hybr. value2
Antimicrobial peptides
210397_at hBD-1 0.9 (1.231) 1.8 (2.214) 0.8 (965)
207356_at hBD-2 915.5 (2.364)* 25.4 (93)* 3.8 (12)
224239_at hBD-3 2.3 (61)* 9.3 (196)* 1.9 (41)
205916_at Psoriasin 25.1 (11.852)* 17.2 (5.597)* 1.5 (385)
203021_at SLPI 2.6 (3.493)* 6.8 (9.010)* 2.1 (2.939)
203691_at SKALP/elafin 176.7 (5.854)* 44.6 (3.861)* 4.1 (284)
234700_s_at Rnase 7 0.9 (276) 43.3 (4.777)* 6.8 (866)
212531_at NGAL 3.5 (207)* 5.5 (378)* 3.2 (175)
202018_s_at Lactoferrin 73.1 (353) 16.6 (59) 10.0 (70)
1555745_a_at Lysozyme 4.8 (319)* 0.3 (26) 0.7 (34)
210244_at hCAP-18/LL37** — — — — — —
202917_s_at Calgranulin A 19.9 (14.879)* 57.8 (13.324)* 29.2 (3.993)
203535_at Calgranulin B 129.5 (11.348)* 161.1 (8.639)* 56.9 (2.607)
232170_at S100A15 217.2 (1.426)* 1.4 (19) 1.0 (11)
205513_at Haptocorrin 146.3 (346.1)* 2.9 (39.6)* 0.7 (8.4)
Interleukins
210118_s_at IL-1a 3.3 (117)* 7.8 (232)* 2.1 (54)
205067_at IL-1ß 6.7 (178) 1.2 (44) 0.9 (32)
205207_at IL-6 22.9 (252)* 119.4 (6.018)* 21.3 (3.226)
206693_at IL-7 0.6 (39) 0.0 (6)* 0.1 (14)
202859_x_at IL-8 68.3 (1.074)* 269.3 (7.169)* 81.4 (3.458)
231169_at IL-14 1.2 (147) 0.3 (19) 0.3 (16)
209827_s_at IL-16 1.2 (147) 0.2 (28)* 0.3 (37)
206295_at IL-18 0.9 (840) 0.3 (273)* 0.6 (504)
224071_at IL20 48.1 (73)* 111.7 (382)* 23.3 (165)
206569_at IL24 64.3 (130)* 184.4 (1005)* 37.0 (166)
207113_s_at TNF-a 2.3 (47)* 3.1 (43) 5.3 (77)
204470_at CXCL1 7.1 (115)* 107.9 (2.493)* 18.1 (443)
Kerationcyte specific marker
209351_at KRT14 1.1 (13.004) 0.9 (9.455) 0.9 (9.734)
1Fold changes between non-wounded skin and wounded skin at day 4. Results are shown as the average of three donors in both the in vivo and ex vivo
groups.
2The average expression intensity is depicted within the parentheses. The expression intensity was normalized to an average intensity of 100 for all genes.
Only genes expressed above the threshold level are depicted with the exception for hCAP18/LL-37.
*Significantly differentially expressed between injured skin and non-injured skin according to Statistical Analysis of Microarray (SAM) with a false discovery
rate of 1.56 %.
**Although the hCAP18/LL-37 probe set displayed absent calls in the arrays of all 15 skin samples a slight but not significant increase in hybridization values
could be seen in wounded skin in vivo but not ex vivo.
www.jidonline.org 1169
KM Roupe´ et al.
Role of Injury in Epidermal Innate Immunity
was therefore further investigated at the protein level by
immunohistochemistry, where prominent expression was
found indicating that lactoferrin was also induced in
keratinocytes in skin wounds (Figure 1).
To examine the role of injury for the epidermal innate
immune responses, we used an ex vivo skin injury model. In
this model, there is limited stimulation from infiltrating
inflammatory cells and changes in gene expression will
therefore primarily be due to the epidermal response to injury
(see Supplementary Table 1). We found good agreement
between the AMP expression pattern in the ex vivo models
and skin wounds in vivo (Table 1). Indeed, out of the
11 AMPs induced in skin wounds, S100A15 was the only
AMP not to also be induced in the ex vivo injured skin. In
addition, the expression levels of lactoferrin, hBD-2, and
haptocorrin were much lower in the ex vivo skin injury
model, suggesting that inherent epidermal reaction to injury
was not a principal inducer of these AMPs in skin wounds.
Apart from these exceptions, the microarray findings in the
two models showed that out of the 11 AMPs significantly
induced in skin wounds, only 4 were not induced primarily
through the epidermal response to injury. Thus, expression
levels of hBD3, psoriasin, SLPI, elafin, NGAL, and calgranu-
lins A and B were all induced through an injury-induced
mechanism.
To regard a gene as upregulated by injury-induced EGFR
activation in keratinocytes in skin wounds in vivo, we esta-
blished the following three criteria that should be met: (1) the
gene should be upregulated both in skin wounds in vivo and
in the ex vivo skin injury model; (2) AG-1478, a specific
inhibitor of the EGFR-associated tyrosine kinase, should
inhibit upregulation of the gene in the ex vivo skin injury
model; and (3) the expression of the gene should be induced
in primary keratinocytes after stimulation with transforming
growth factor a (TGF-a), a potent and selective ligand of
the EGFR. We have previously found that NGAL, SLPI, and
hBD-3 meet these criteria (Sørensen et al., 2003, 2006).
Microarray and qRT-PCR analyses indicated that the induc-
tion of the other major injury-induced AMPs, that is psoriasin,
elafin, and calgranulins A and B, in all cases was inhibited by
AG-1478 in the ex vivo skin injury model, thereby meeting
criterion 2 (Table 1). The inhibition with AG-1478 was
confirmed by qRT-PCR data showing more than 90%
inhibition in three independent experiments. Stimulation of
primary keratinocytes with TGF-a further caused a robust
induction of these AMPs both at the mRNA level deter-
mined by qRT-PCR and at the protein level, thereby fulfilling
criterion 3 (Figures 2a and b). These data showed that
psoriasin, elafin, and the calgranulins were induced by EGFR
activation in skin wounds. To the best of our knowledge,
these findings are previously unreported.
The major chemotactic activity in injured skin is generated by
EGFR-dependent IL-8 expression
The gene expression for a set of chemokines and cytokines
important in the epidermis was analyzed in skin wounds
in vivo and in the ex vivo skin injury model. We found
significant upregulation of IL-1, IL-6, and IL-8 mRNA levels,
confirming previous reports. In addition, we found a
significant increase in IL-20 and IL-24 mRNA levels. This
induction was further confirmed by qRT-PCR (data not
shown). The important neutrophil chemoattractant IL-8 was
the IL most strongly induced both in skin wounds and in
injured skin ex vivo. This was paralleled by the induction of
CXCL-1 (GRO-a), another major chemoattractant for neu-
trophils (Table 1). There was again good agreement between
the in vivo and ex vivo wound model.
The expression of all these injury-induced cytokines and
chemokines was inhibited by AG-1478 in the ex vivo skin
injury model (Table 1). For IL-8, this inhibition was confirmed
at the protein level by western blot analysis of medium from
ex vivo wounded skin (Figure 3a). In experiments with
cultured keratinocytes, we observed a strong upregulation of
IL-8 mRNA levels after stimulation with TGF-a (Figure 3b).
We also found a 23-fold upregulation of CXCL-1, a 12-fold
upregulation of IL-20, and a 47-fold upregulation of IL-24 by
qRT-PCR (average of three independent experiments). The
EGFR-dependent induction of IL-6 in keratinocytes is also in
agreement with previous observations in vitro (Aragane et al.,
1996). According to our criteria, the five epidermal cytokines
(IL-6, IL-8, IL-20, IL-24, and CXCL-1) were, thus, induced in
skin wounds in vivo through activation of the EGFR pathway.
To investigate a functional role of the injury-induced
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Figure 2. Expression of AMPs and cytokines in stimulated human
keratinocytes. (a) Primary human keratinocytes were stimulated for
24 and 48 hours with TGF-a (50 ng ml1). RNA was purified and cDNA was
synthesized. The gene expression for psoriasin, elafin, calgranulins, and
S100A15 were analyzed by qRT-PCR and the expression was normalized to
housekeeping gene G3PDH and depicted as fold-induction compared with
non-stimulated controls. The average of three independent experiments is
shown. (b) Medium (Med.) or extracts (Ext.) from stimulated human
keratinocytes were subjected to SDS-PAGE, then blotted and probed
with antibodies to psoriasin, calgranulin B, and elafin.
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cytokines, chemotaxis experiments were performed with the
medium from the ex vivo injured epidermis. Prominent
chemotactic activity toward neutrophils was found in the
medium from ex vivo injured epidermis (Figure 3c). Neutra-
lizing IL-8 antibodies completely abolished the chemotactic
effect of the medium (n¼3, Po0.02), whereas control
antibodies or neutralizing antibodies against CXCL-1 had
no significant effect.
To establish a link between the injury-induced EGFR
activation and the attraction of neutrophils to the wound,
chemotaxis experiments were performed with the medium
from ex vivo injured skin treated with AG-1478. This
treatment significantly reduced the chemotactic activity
(450%) generated in the ex vivo injured skin (Po0.01,
n¼5) (Figure 3e). Control experiments showed that AG-1478
by itself did not inhibit chemotaxis (data not shown).
Analysis of the time of IL-8 expression in the ex vivo
injured skin showed induction already at day 1 (Figure 3d)
(earliest time points tested). This is in contrast with the
EGFR-dependent gradual increase in AMP expression
(Figure 1). TGF-a stimulation of keratinocytes resulted in
maximal IL-8 expression already after 3–6 hours (Figure 3c),
whereas expression of AMPs such as SLPI, NGAL, and
hBD-3 peaked after 48 hours (Sørensen et al., 2003). Thus,
EGFR activation leads to a much more rapid expression
of IL-8 than that of AMPs both in cultured keratinocytes
in vitro and in ex vivo injured skin. Stimulation of primary
keratinocytes showed that the observed AMP expression by
EGFR activation was not a direct effect due to IL-8 (data not
shown).
Injury is independently of infection a major inducer of AMP
expression in mouse skin wounds
To study the importance of injury for the epidermal innate
immune responses in vivo, mouse skin experiments were
performed. We have previously shown that injury of mouse
skin induces the murine orthologs of SLPI and NGAL (named
24p3 in mouse) both in vivo and in the ex vivo skin injury
model (Sørensen et al., 2006). We further examined the
mRNA expression of the murine b-defensins (mBD)-1 through
6 as well as the expression of mBD-14, the murine ortholog of
hBD-3 (Hinrichsen et al., 2008; Ro¨hrl et al., 2008), in murine
skin wounds by qRT-PCR. Only mBD-3 was induced in the
ex vivo mouse skin injury model (Figure 4a) and in skin
wounds in vivo along with the previously shown SLPI and
24p3 (data not shown). To investigate the importance of
injury compared with infection for AMP expression in skin
wounds, we analyzed AMP expression during topical
cutaneous infections in mouse skin. AMP expression was
not induced in topically infected intact skin (data not shown).
We subsequently perforated the skin using a syringe before
the application of bacteria. No significant increase in
expression levels of SLPI, 24p3, mBD-3, or any of the
examined mBDs was found compared with non-infected skin
controls perforated the same way (Figure 4b). To validate that
this was not due to inadequate microbial stimulation, we
incubated ex vivo injured mouse skin with peptidoglycan
(PGN) and investigated the induction of AMP expression.
This experimental setup gives very prominent AMP induction
in human skin (Liu et al., 2003; Sørensen et al., 2005).
However, the expression of SLPI, 24p3, and mBD-3 mRNA
levels in the ex vivo injured mouse skin were not further
induced by PGN stimulation (Figure 4c). Importantly, PGN
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Figure 3. EGFR-dependent IL-8 is the major chemotactic cytokine released
from injured skin. (a) IL-8 blot performed on medium from ex vivo wounded
skin (WM.) incubated with or without AG1478. (b) The time course of
induction of IL-8 was studied by monitoring the mRNA levels by qRT-PCR in
TGF-a-stimulated keratinocytes and non-stimulated keratinocytes. The chart
depicts the difference in mRNA levels (ddCt) in normalized threshold
cycles (dCt) (calculated by subtracting the IL-8 threshold cycles (Ct) from
the threshold cycles of the G3PDH housekeeping gene that was used as
reference) between stimulated wells compared with non stimulated controls.
One representative experiment out of three is shown. A considerable
induction was always found already at day 0. (c) Chemotaxis of human
neutrophils was measured with medium from the ex vivo injured
skin/epidermis as neutrophil chemoattractant. IL-8-neutralizing antibodies
inhibited the chemotactic activity of the medium from the ex vivo injured
human skin (Po0.02, n¼ 3), but pre-immune control antibodies or
CXCL-1-neutralizing antibodies had no effect. (d) IL-8 expression in injured
human skin ex vivo. The change in mRNA expression (ddCt) is shown
as the difference in normalized IL-8 threshold cycles (dCt) from each day
and the control at day 0. (G3PDH was used as reference gene.) One
representative experiment out of three is shown. (e, f) The chemotactic
activity in medium from ex vivo injured skin was measured both in humans
and in mice. (e) Medium from ex vivo injured human skin treated with
AG-1478 displayed significantly lower chemotactic activity toward
neutrophils (Po0.01, n¼ 5) than the medium from ex vivo injured skin
treated with DMSO vehicle. (f) No significant difference in chemotactic
activity could be seen between medium from ex vivo injured mouse skin
treated with AG-1478 compared with medium from ex vivo injured
mouse skin treated with DMSO vehicle (P40.75, n¼ 4). **Po0.01.
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also failed to induce the expression of any of the other
mBDs (data not shown). Similar results were obtained when
stimulating with lipopolysacharide (data not shown). These
data showed that injury was a major inducer of epidermal
AMP expression in mouse skin wounds independent of
infection.
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skin. Dorsal mouse skin was sliced in 1 10 mm pieces and cultured in keratinocyte medium before mRNA extraction at 24, 48, 76, and 96 hours. The change
in mRNA expression (ddCt) is shown as the difference in threshold cycles (Ct) of the gene of interest after normalizing each gene with G3PDH and control at
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24p3 already at day 1. (b) Topical skin infection with S. aureus or S. pyogenes strain AP1 was performed in Balb/c mice (see Experimental procedures).
The infected area of epidermis was excised and the gene expression was analyzed by qRT-PCR with non-infected epidermis from the same mouse as control.
The gene expression was normalized to G3PDH and changes in threshold cycles (Ct) were compared with the non-infected control area (ddCt). Each value
represents an average of three mice. (c) Ex vivo wounded mouse skin was incubated with medium with 5% serum with or without peptidoglycan (PGN) and the
gene expression analyzed by qRT-PCR. The mRNA expression is shown as the difference in threshold cycles (Ct) of the gene of interest (ddCt) after normalizing
each gene with G3PDH and control day 0. Results from two independent experiments are shown. (d) SLPI mRNA expression levels were monitored by
qRT-PCR in ex vivo injured mouse skin after 48 hours. The skin slices were incubated with DMSO vehicle, AG-1478, AG-879, anti-TNFa, IL-1b, and
TAPI-1. The mRNA expression is shown as the difference in threshold cycles (Ct) between the gene of interest (ddCt) after normalizing each gene with
G3PDH and day 0. Each value represents a minimum of four separate experiments. (Similar results were obtained for 24p3 and mBD-3.) (e) Primary
murine keratinocytes were stimulated for 24 and 48 hours with cytokines and growth factors. RNA was purified and cDNA was synthesized. Gene expression
was analyzed by qRT-PCR and the expression was normalized to housekeeping gene G3PDH and the changes in threshold cycles (ddCt) were compared
with non-stimulated controls. The average of three independent experiments is shown. Left panel: Gene expression of mBD-3, murine SLPI, and 24p3.
Right panel: Gene expression of mBD-2 in response to IL-1b and TNFa. (f) Medium from stimulated murine keratinocyte was subjected to SDS-PAGE
and then blotted and probed with antibodies to murine SLPI and 24p3.
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Injury induces chemotactic activity in mouse skin
The main chemokine induced in the experiments with
injured human epidermis, IL-8, is not found in mice. By
qRT-PCR, we failed to detect any expression of the murine
neutrophil chemoattractants CXCL-1 (GRO-a) and CXCL-3
(KC) in the non-injured mouse skin. However, these
cytokines were clearly expressed in the ex vivo skin injury
model (data not shown). The mouse ortholog of IL-8, CXCL2
(MIP-2), could not be detected neither in non-injured nor in
injured skin (data not shown). As with the human model,
medium from the ex vivo injured mouse skin showed
prominent chemotactic activity toward human neutrophils
(Figure 3f).
Injury-induced epidermal innate immune responses are
differently regulated in human and mouse skin
To investigate the molecular mechanism for the injury-
induced AMP and cytokine expression in mouse skin, we
first tested the ability of AG-1478 and AG-879 (a broader
inhibitor of the homology to EGF receptor family) to inhibit
the injury-induced expression of AMPs in the ex vivo injured
mouse skin. However, these inhibitors did not block the
injury-induced AMP expression (Figure 4d). Furthermore,
neither the injury-induced chemotactic activity generated
in the mouse epidermis nor the expression of CXCL-1 or
CXCL-3 was inhibited by AG-1478 (Figure 3f and data
not shown). We also tested TNF-a-converting enzyme
protease inhibitor-1 (TAPI-1), a metalloprotease inhibitor
that inhibits the shedding of membrane-bound EGFR ligands
during transactivation. In contrast to in injured human
skin (Sørensen et al., 2006), TAPI-1 did not inhibit AMP
expression in injured mouse skin (Figure 4d). Furthermore,
stimulation of primary murine keratinocytes with TGF-a did
not cause significant induction of SLPI, 24p3, and mBD-3
mRNA expression even in combination with insulin-like
growth factor 1 (Figure 4e and f) that potentiates the AMP
expression of TGF-a in human keratinocytes (Sørensen et al.,
2003). Accordingly, EGFR activation did not induce expres-
sion of AMPs in murine keratinocytes neither in in vitro nor in
injured epidermis ex vivo.
Next, we investigated whether three pro-inflammatory
cytokines known to induce AMPs in human keratinocytes,
IL-1, TNF-a, and IFN-g, could induce AMP expression in
murine keratinocytes. We found induction of mBD-3, 24p3,
and SLPI after stimulation with IL-1b and TNF-a after 24 and
48 hours as well as a minor effect of IFN-g (Figure 4e and f). In
addition, these cytokines induced the expression of mBD-2
(Figure 4e, right panel) but not of any of the other mBDs. We
then tested whether the IL-1 receptor antagonist or TNF-a-
neutralizing antibodies inhibited the injury-induced AMP
expression in the ex vivo mouse skin injury model. Neither
the IL-1 receptor antagonist nor the anti-TNF-a-neutralizing
antibodies inhibited the injury-induced AMP expression in
mouse skin (Figure 4d), indicating that injury-induced AMP
expression in mouse skin was not mediated by IL-1 or TNF-a.
This was substantiated by the fact that mBD-2, inducible by
both IL-1 and TNF-a, was not expressed in the ex vivo skin
injury model.
DISCUSSION
Epidermal injury represents a vulnerable condition where the
normal physical barrier of intact skin protecting against
microbes is disrupted. In accordance with the ‘‘danger model
of immunity’’ (Matzinger, 2002), injury can therefore be seen
as a danger signal that elicits innate immune responses in the
wound, including production of AMPs and chemotactic
cytokines attracting neutrophils. In this study, we attempted
do delineate the importance of injury for the epidermal innate
immune response during wound healing. We found that the
major epidermal production of cytokines and AMPs in skin
wounds was independent of stimulation from infiltrating
inflammatory cells and that it represented an epidermal
response to injury. The importance of injury for the epidermal
innate immune responses found in the human models was
corroborated in vivo by mouse experiments showing that
injury has a major role in epidermal AMP expression in skin
wounds independent of wound infections.
In human skin, the injury-induced EGFR activation was
shown to be of major importance for the epidermal AMP
expression. Interestingly, the same molecular pathway was
clearly also involved in the production of chemotactic
cytokines attracting neutrophils to the wound. Thus, we
found that EGFR-dependent IL-8 production in response to
injury was a major contributor to the potent chemotactic
activity toward neutrophils generated in the injured epider-
mis. Interestingly, the dynamics of IL-8 expression found in
the ex vivo injured epidermis, with a rapid induction of
mRNA expression followed by a more gradual increase until
days 3–4 after injury, fits well with the pattern of increasing
concentrations of IL-8 in wound fluid from skin wounds
in vivo peaking around day 5 (Rennekampff et al., 2000).
Thus, injury-induced EGFR-dependent IL-8 production pro-
vides a molecular link between tissue injury and neutrophil
recruitment in human skin.
The injury-induced epidermal immune responses elicited
by keratinocytes that encompass rapid production of IL-8
followed by a more gradual increase in the production of
epidermal AMPs should be viewed in the context of other
processes taking place after cutaneous injury (Werner and
Grose, 2003). The keratinocyte response requires active
protein synthesis and these cells are therefore not likely to be
critically involved in the initial antimicrobial defense after
epithelial injury. The first major event in a skin wound after
injury is the exudation of plasma resulting both in activation
of the complement system and in coagulation mediated
through the intrinsic pathway (the contact system) (Kiritsy
et al., 1993). Recent studies have shown that activation of
both these catalytic cascades leads to the generation of
antimicrobial peptides (Nordahl et al., 2004; Frick et al.,
2006). Additional AMPs are released from activated platelets
(Tang et al., 2002) at this stage. The complement activation
also leads to attraction of leukocytes through the generation
of chemotactic factors such as C3a and C5a. Simultaneously,
epidermal injury leads to the activation of metalloproteases
that results in shedding of growth factors, which subsequently
activate the EGFR (Tokumaru et al., 2000). Injury-induced
EGFR activation causes IL-8 production in keratinocytes
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which is likely to be important for the continued neutrophil
recruitment to the wound. As inflammation starts to recede
and neutrophil count diminish the epidermal EGFR-depen-
dent AMP expression reaches its maximum.
Mice experiment confirmed the important role of injury
independent of infection for AMP expression during wound
healing. However, we found important differences in the
regulation of AMP expression between murine and human
skin wounds. Although the injury-induced production of
cytokines and AMPs were dependent on EGFR-activation in
human skin, this was not the case in murine skin. Indeed,
EGFR activation failed to induce AMP expression in murine
keratinocytes even in vitro. In addition, superficial skin
infection did not induce AMP expression in murine skin or
skin wounds in vivo. Lipopolysacharide and PGN, both
potent microbial inducers of AMP expression in injured
human skin ex vivo (Liu et al., 2003; Sørensen et al., 2005),
failed to induce AMP expression in mouse skin when using
the exact same experimental setup. Accordingly, both the
molecular mechanism of injury-induced AMP and cytokine
expression, as well as the response to cutaneous infection/
microbial stimuli, differ between human and murine skin.
These observed differences indicate that care must be taken
when extrapolating mouse data regarding innate immunity in
skin to the human situation.
In conclusion, we found that injury was a major inducer of
the epidermal innate immune responses encompassing
expression of AMPs and cytokines. Mouse experiments
confirmed that injury was the major inducer of epidermal
innate immune responses in vivo independent of the
presence of wound infections. The epidermal injury res-
ponses generated chemotactic activity in the epidermis due
to EGFR-dependent IL-8 production, thus, providing a, to our
knowledge previously unreported, molecular link between
tissue injury and neutrophil recruitment.
MATERIALS AND METHODS
Reagents
The anti-hBD-2 and anti hBD-3 antibodies have been described
previously (Liu et al., 2002; Sørensen et al., 2005) and were
generously provided by Dr. Tomas Ganz (University of California,
Los Angeles). Antibodies to SLPI, IL-8, elafin, and murine IL-1
receptor antagonist were purchased from R&D Systems (Minneapolis,
MN), whereas psoriasin antibodies were purchased from Biocarta
(San Diego, CA) and haptocorrin antibodies from Abcam (Cambridge,
UK). Normal rabbit immunoglobulins, anti-murine TNF-a, CXCl-1,
and CXCL-3 antibodies, anti-human CXCL-1 antibodies, murine
IFN-g, murine insulin-like growth factor 1, murine IL-1b, murine
IL-6, murine TNF-a, human TGF-a, and human IL-8 were all
from Peprotech (Rocky Hill, NJ). N-formyl-methionyl-leucyl-
phenylalanine, AG-1478, and AG-879 were purchased from Sigma
(St. Louis, MO). TAPI-1 was from Peptides International (Louisville,
KY). Lipopolysacharide and PGN were from Sigma.
Human skin wounds
Samples from human skin wounds were obtained under protocols
approved by the Ethics Committee at Lund University (Lund,
Sweden). Informed written consent was obtained from all subjects
and all procedures in this study involving human samples were
performed in accordance with the guidelines in the Declaration of
Helsinki Principles. Non-wounded human skin was obtained by
taking punch biopsies from three healthy donors and skin wound
samples were retrieved by making new punch biopsies from the
edges of the initial biopsies. These samples were fixed in formalin for
immunohistochemistry. For analysis by cDNA microarray, as much
dermal tissue as possible was removed by dissection from the
biopsies. The remaining tissue was subsequently washed thoroughly
in sterile NaCl to remove infiltrating inflammatory cells. This ensured
that the samples mainly consisted of the epidermis (Figure 1 in the
Supplementary material). RNA was isolated from these samples and
used for cDNA microarray analysis.
Model of ex vivo injured human skin
Skin was obtained from three donors after informed written consent,
following reduction surgery of the abdomen (normal skin) according
to protocols approved by the Ethics Committee at Lund University and
in accordance with the ethical principles in the Helsinki declaration.
The skin biopsies were cut into slices of 1 10 mm and incubated in
culture for 4 days (ex vivo injured skin). Furthermore, as much non-
epidermal tissue as possible was removed by dissection and the
samples were washed. The skin samples were cultured in serum-free
keratinocyte medium (KGM2 Bullet kit) from Cambrex (Walkersville,
MD) supplemented with transferrin, hEGF (0.15 ng ml1), 0.5 mg ml1
hydrocortisone, gentamicin, amphotericin B, and epinephrine but
without insulin (all supplied by Cambrex). We previously found that
this medium does not induce the expression of AMPs in keratinocytes
(Sørensen et al., 2003). Indeed, even 100 ng ml1 of epidermal growth
factor gives a very limited AMP induction (Sørensen et al., 2005).
In the inhibition experiments, the skin slices were incubated with
AG-1478 at a final concentration of 10mmol l1. RNA was isolated
from these samples and used for cDNA microarray analysis. The
medium with injured skin was changed every 2 days, and medium
from days 2 to 4 was used for chemotaxis experiments.
Experiments with ex vivo injured mouse skin
Mice were killed by CO2 asphyxiation and cervical dislocation.
A dorsal portion of the skin was shaved, surgically removed, and cut into
slices of 1 10mm. Approximately 25 skin pieces were incubated in
six-well plates in 5ml keratinocyte serum free medium (SFM) (Invitrogen,
Carlsbad, CA) supplemented with 5ngml1 bovine pituitary extract,
5ng ml1 recombinant EGF, and a antibiotic/antimycotic solution
consisting of 1,000 unitsml1 penicillin G sodium, 1,000 unitsml1
streptomycin sulfate, and 0.25mgml1 amphoteracin B (Invitrogen). For
inhibition experiments, IL-1 receptor antagonist was used in a concen-
tration of 250ngml1, AG1478 and AG879 at 10mmol l1, and TAPI-1
at 50mmol l1 and anti-TNFa antibody at 7.5mgml1. For stimulation
with microbe-derived molecules, PGN was used in a concentration
10mg ml1 and lipopolysacharide in a concentration of 100ngml1.
Isolation of polymorphonuclear neutrophils
Polymorphonuclear neutrophils were isolated at 4 1C from blood
from healthy donors using gradient centrifugation (Bo¨yum, 1968).
EDTA-stabilized whole blood (5 ml) was placed on 3 ml Polymorf-
prep (Nycomed AS, Oslo, Norway) and centrifuged for 35 minutes at
400 g. The granulocyte layer was harvested and resuspended in
Hanks’ buffered salt solution (Gibco, Life Technologies, Rockville,
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MD), washed three times, and centrifuged for 7 minutes at 900 g.
Polymorphonuclear neutrophils were then resuspended (2.0 106
cells per ml) in Hanks’ buffered salt solution with 0.2% human
serum albumin (Behring, Marburg, Germany).
Chemotaxis
Neutrophil chemotaxis was assessed as previously described
(Nybo et al., 1998). Briefly, a 48-well microchemotaxis chamber
(NeuroProbe, Gaithersburg, MD) with 3-mm Millipore filters, type SS
(Millipore, Billerica, MA), was used. Media from ex vivo wounded
skin were subsequently tested as chemoattractant. Survival of
fibroblast and other non-keratinocyte cells are not supported by
the growth media in the ex vivo skin injury model. Accordingly, we
used media incubated with the ex vivo injured skin from days 2 to 4.
Using this media made it possible to selectively investigate
chemotactic factors secreted by the epidermal keratinocytes. In
some experiments, neutralizing antibodies (5 mg/ml) toward the
different chemokines were added to the incubation medium before
the chemotaxis experiments. N-formyl-methionyl-leucyl-phenylala-
nine (108 mol l1) was used as a positive chemoattractant control.
Polymorphonuclear neutrophils were placed in the microchemotaxis
chamber for 30 minutes at 37 1C, and directed migration was
subsequently measured by the leading-front principle (Zigmond
and Hirsch, 1972) with three cells per high-power field. Three fields
were read per well, and all samples were assayed in duplicate. All
migration distances were subtracted, and the spontaneous migration
was measured in non-stimulated polymorphonuclear neutrophils
and expressed as micrometer per 30 minutes.
SDS-PAGE and immunoblotting
SDS-PAGE and immunoblotting were carried out according to
the instructions from the manufacturer (Bio-Rad, Hercules, CA). After
transfer of proteins from the polyacrylamide gels, the polyvinylidene
difluoride membrane was fixed for 30 minutes in Tris buffered saline
with 0.05% glutaraldehyde (Sigma) and blocked with 3% skimmed
milk. For visualization of the poly(peptides), the polyvinylidene
difluoride membranes were incubated overnight with primary anti-
bodies. The next day, the membranes were incubated for 2 hours with
HRP-conjugated secondary antibodies (Dako, Glostrup, Denmark) and
visualized by SuperSignal West Pico Chemiluminescent Substrate
(Thermo Scientific, Rockford, IL).
Keratinocyte culture
Primary human keratinocytes were obtained from Cascade Biologics
(Portland, OR) and cultured in serum-free medium (KGM2 Bullet kit)
from Cambrex. Cells were stimulated, beginning 24 hours after
complete confluence was reached and stimulated with TGF-a
(50 ng ml1) for 3, 6, 12, 24, and 48 hours or left non-stimulated
as control. Primary mouse keratinocytes (CellnTech, Bern,
Switzerland) were cultured in six-well plates in CnT-02 medium
(CellnTech). The medium was changed every 2 days until
confluence was reached. Murine keratinocytes were stimulated the
day after complete confluence was reached with the following
mouse cytokines: IL-1b (25 ng ml1), IL-6 (100 ng ml1), TGF-a
(50 ng ml1), TNF-a (25 ng ml1), insulin-like growth factor 1
(100 ng ml1), and INF-g (50 ng ml1) for 24 and 48 hours before
harvesting cells for mRNA extraction and medium for western blot
analysis. Cells grown in medium were used as control.
Immunohistochemistry
The specimen were fixed in 10% formalin, dehydrated, and
embedded in paraffin. Sections of 5-mm thickness were placed
on poly-lysine-coated glass slides, deparaffinized in xylene, and
rehydrated in graded alcohols. The slides were then treated with
Dako antigen retrieval solution (Dako) for 40 minutes at 97 1C. The
slides were incubated for 24 hours at room temperature in a 1:1,000
dilution of polyclonal antibodies. The antibodies were diluted in TBS
with 0.05% Tween 20, 1% BSA, and 5% serum from the same
species as the secondary antibody. After three 20-minute washes in
TBS with 0.05% Tween 20, the slides were incubated with alkaline
phosphatase-conjugated secondary anti IgG (Dako) diluted 1:1,000
in the same buffer as the first antibody and incubated for another
24 hours followed by three 20-minute washes. Color was developed
with Vulcan Fast Red chromogen (Biocare Medical, Concord, CA)
and the slides were counterstained with Harris Hematoxylin
(EM Science, Gibbstown, NJ).
Bacterial strains and growth conditions
The Streptococcus pyogenes strain AP1 of the M1 serotype was from
the WHO Collaborating Centre for Reference and Research on
Streptococci, Institute of Hygiene and Epidemiology (Prague, Czech
Republic). Staphylococcus aureus was a clinical isolate from
Department of Microbiology (Lund University Hospital). Bacteria
from overnight cultured plates were grown in 10-ml Todd
Hewitt broth (Becton, Dickinson and Company, Sparks, MD) with
yeast extract (Becton, Dickinson and Company) at 37 1C and 5%
CO2. Bacteria were taken in stationary phase after a 16-hour
culture. Before use, bacteria were washed twice in sterile
physiological salt solution. Optical density was measured at
620 nm and bacteria were diluted to a calculated concentration
estimated from previously established growth curves. All colony-
forming unit (CFU) given values were based on triplicate plating
assay results.
Topical skin infection in vivo
Wild-type C57BL/6 mice, 7- to 8-week old, were anesthetized with
isoflorane and a small dorsal area of the skin was shaved and
sterilized with ethanol. The shaved area was punctured four times
at two places using a syringe needle (BD Microlance, Drogheda,
Ireland, 0.3 19 mm) (MidMeds, Waltham Abbey, UK)). Two rubber
rings with 10-mm inner diameter were subsequently attached using
an ethylcyanoacrylate-based adhesive and the rings were covered
with OpSite (Medisave, Weymouth, UK). CFU (2 107 or 1 1011)
of S. pyogenes and CFU (3.2 107 or 1.1 109) of S. aureus in a
volume of 150ml was thereafter injected through the OpSite into
the cavity formed by one of the rubber rings. The other ring
was injected with sterile buffer and used as control. Mice were
killed after 2 days and the skin within the side of the rings was
retrieved for RNA purification and qRT-PCR analysis. All animal
experiments were approved by the Animal Welfare Committee at
Lund University.
RNA isolation
Total RNA was isolated with Trizol (Invitrogen) according to the
recommendations of the supplier and resuspended in 0.1 mmol l1
EDTA. The concentration was determined by spectrophotometric
measurement.
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Real-time PCR
cDNA was synthesized from 200 ng purified RNA using iScript
cDNA synthesis kit (Bio-Rad) according to the instructions given by
the manufacturer. hBD-1, hBD-2, and hBD-3 together with G3PDH
expression was analyzed using iQ SYBR Green Supermix (Bio-Rad).
Primers for real-time PCR are described in Supplementary material.
Amplification was performed at 55 1C for 40 cycles in iCycler
Thermal Cycler (Bio-Rad) and data analyzed using iCycler iQ
Optical System Software. The relative expression in each sample was
calculated by a mathematical method based on the real-time PCR
efficiencies (Pfaffl, 2001).
Microarray analysis
For gene expression analysis, total RNA was biotinylated
and hybridized to Human Genome U133 Plus 2.0 GeneChips
(Affymetrix, Santa Clara, CA) according to the instructions by the
manufacturer. The microarray fluorescence signals were norma-
lized using the GeneChip Operation Software (GCOS ver. 1.4,
Affymetrix). All probe set lists were annotated with locus link
identifications (IDs) provided by the NetAffx database (Affymetrix,
www.affymetrix.com) and converged into gene/EST (expressed
sequence tag) lists by exclusion of redundant probe sets with
identical locus ID. Genes were defined as expressed in cell popula-
tions if all replicates were assigned a present call by the GCOS
software (Affymetrix). Genes of potential interest for wound healing
were therefore only genes with at least three present calls in either
the in vivo control condition or in the in vivo wound condition.
These genes were each assigned a Z-score, calculated on the basis
of the log2 hybridization values of their probes on each microarray,
in order to get a better comparison between arrays. The statistical
technique Significance Analysis of Microarrays (SAM) was subse-
quently used in order to determine which of these genes that could
be considered differentially expressed based on the Z-scores of the
triplicate biological samples. The cutoff was set to include expres-
sion of three AMPs, hBD-3, NGAL, and SLPI, previously found to be
induced in skin wounds. This gave a false discovery rate of 1.57 %.
Statistical analysis
For non-microarray data, two-tailed paired Student’s t-test was used.
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